Yaping Yang Selected Research

Language Development Disorders (Semantic-Pragmatic Disorder)

1/2021	Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies.
10/2017	Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.
1/2017	Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
1/2017	Erratum to: Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
1/2014	Lysinuric Protein Intolerance Presenting with Multiple Fractures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaping Yang Research Topics

Disease

26	Neoplasms (Cancer) 11/2022 - 01/2013
20	Breast Neoplasms (Breast Cancer) 11/2022 - 04/2014
12	Intellectual Disability (Idiocy) 01/2021 - 02/2013
11	Inflammation (Inflammations) 06/2021 - 01/2014
6	Infections 12/2021 - 01/2012
6	Neurodevelopmental Disorders 01/2021 - 01/2017
5	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2021 - 01/2014
5	Microcephaly 01/2021 - 02/2017
5	Acute Lung Injury 06/2020 - 01/2017
4	Pneumonia (Pneumonitis) 06/2021 - 01/2017
4	Stomach Neoplasms (Stomach Cancer) 02/2019 - 01/2013
4	Seizures (Absence Seizure) 01/2018 - 11/2015
4	Autism Spectrum Disorder 01/2017 - 09/2015
3	Ischemia 09/2021 - 01/2019
3	Autistic Disorder (Autism) 01/2019 - 09/2015
3	Nasopharyngeal Carcinoma 11/2018 - 01/2017
3	Epilepsy (Aura) 12/2016 - 06/2012
3	Trichinellosis 01/2014 - 01/2008
2	Demyelinating Diseases (Demyelinating Disease) 02/2022 - 02/2016
2	Cognitive Dysfunction 09/2021 - 06/2012
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2016
2	Facies 01/2021 - 01/2016
2	Endometritis 03/2019 - 01/2018
2	Retinal Degeneration 01/2019 - 01/2016
2	Leigh Disease (Leigh's Disease) 01/2019 - 02/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018 - 11/2018
2	Atrophy 12/2018 - 03/2014
2	Congenital Heart Defects (Congenital Heart Defect) 10/2018 - 01/2018
2	Lung Injury 01/2018 - 01/2017
2	Colitis 01/2017 - 01/2014
2	Brain Diseases (Brain Disorder) 12/2016 - 06/2012
2	Dwarfism 01/2016 - 12/2015
1	Melanoma (Melanoma, Malignant) 06/2022
1	Brain Ischemia (Cerebral Ischemia) 02/2022
1	Pathologic Complete Response 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Pterygium 10/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2009
7	LipopolysaccharidesIBA 01/2020 - 01/2017
6	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2018
5	CytokinesIBA 12/2021 - 01/2014
5	Estrogen ReceptorsIBA 01/2020 - 01/2017
4	AntioxidantsIBA 06/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 11/2009
3	Hormones (Hormone)IBA 11/2022 - 01/2017
3	TeaIBA 10/2021 - 01/2016
3	Catechin (Z 7300)IBA 10/2021 - 01/2016
3	Epirubicin (Ellence)FDA LinkGeneric 07/2021 - 05/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2021 - 05/2014
3	ChromatinIBA 01/2021 - 10/2016
3	Carrier Proteins (Binding Protein)IBA 11/2019 - 06/2012
3	sodium iodateIBA 01/2019 - 03/2014
3	Chloride Channels (Chloride Channel)IBA 11/2018 - 06/2017
3	Nonsense Codon (Nonsense Mutation)IBA 01/2018 - 01/2011
3	Amino Acids FDA Link 01/2018 - 02/2013
3	VaccinesIBA 01/2014 - 01/2008
2	Therapeutic UsesIBA 06/2022 - 01/2019
2	AnthracyclinesIBA 01/2022 - 05/2014
2	Biological ProductsIBA 12/2021 - 02/2017
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 07/2021 - 10/2017
2	Letrozole (Femara)FDA LinkGeneric 07/2021 - 10/2017
2	Everolimus FDA Link 07/2021 - 10/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2021 - 05/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2020
2	c-Mer Tyrosine KinaseIBA 04/2020 - 01/2020
2	Circulating Tumor DNAIBA 01/2020 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2018 - 01/2017
2	Tamoxifen FDA LinkGeneric 02/2018 - 05/2014
2	ChloridesIBA 02/2018 - 06/2017
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2016
2	Arginine (L-Arginine)FDA Link 01/2018 - 10/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 01/2017
2	human ERBB2 proteinIBA 10/2017 - 01/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2017 - 01/2017
2	Disulfiram (Antabuse)FDA Link 01/2017 - 11/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017 - 01/2017
2	NucleotidesIBA 01/2017 - 06/2012
2	EnzymesIBA 02/2016 - 09/2015
2	Carnitine (L-Carnitine)FDA LinkGeneric 10/2015 - 09/2015
2	Epidermal Growth Factor (EGF)IBA 02/2013 - 01/2013
1	3,3'-diindolylmethane (diindolylmethane)IBA 06/2022
1	Immune Checkpoint InhibitorsIBA 06/2022
1	Programmed Cell Death 1 ReceptorIBA 06/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2022
1	apatinibIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	eribulin FDA Link 01/2022
1	camrelizumabIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2008
5	Neoadjuvant Therapy 11/2022 - 01/2017
5	Drug Therapy (Chemotherapy) 06/2022 - 05/2014
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 01/2013
3	Segmental Mastectomy (Lumpectomy) 01/2022 - 04/2014
2	Immunotherapy 06/2022 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 09/2017 - 01/2017
1	Catheters 07/2022
1	Radiotherapy 01/2022